Symtuza Tablet, Film Coated
Product Images NDC 59676-800

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Symtuza (NDC 59676-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Symtuza 01)

Chemical structure diagram of Darunavir, one of the active ingredients in Symtuza oral film-coated tablets. The structure includes multiple rings and functional groups characteristic of Darunavir's molecular composition.*

FDA Label Image

Chemical Structure (Symtuza 02)

Chemical structure diagram of the active ingredient Darunavir, showing its molecular arrangement with rings, chains, and functional groups in a detailed 2D format.*

FDA Label Image

Chemical Structure (Symtuza 03)

Chemical structure of Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide, the active ingredients in Symtuza tablets. The diagram shows the molecular arrangement with atoms and bonds, including nitrogen, oxygen, fluorine, sulfur, and carbon components.*

FDA Label Image

Chemical Structure (Symtuza 04)

Chemical structure of Darunavir, a component of Symtuza, a combination tablet containing Darunavir, Cobicistat, Emtricitabine, and Tenofovir alafenamide. The structure includes the chemical groups and spatial configuration characteristic of Darunavir.*

FDA Label Image

Figure 1 (Symtuza 05)

This figure contains two forest plots showing geometric mean ratios (GMR) with 90% confidence intervals for pharmacokinetic parameters of darunavir/cobicistat (left) and cobicistat alone (right) during second and third trimesters of pregnancy. Parameters include total AUC, total Cmin, unbound AUC, and unbound Cmin.*

FDA Label Image

Principal Display Panel (30 Tablet Bottle Label)

Symtuza 800 mg / 150 mg / 200 mg / 10 mg film-coated tablets label shows that each tablet contains darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. The package contains 30 tablets and is labeled by Janssen Products LP. It includes dosage and storage information, NDC 59676-800-30, barcode, and regulatory text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.